Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal

Behavioural Brain Research
B J Cole, T W Robbins

Abstract

Six experiments examined the effects of 6-hydroxydopamine (6-OHDA) induced lesions of the nucleus accumbens septi (NAS) on performance of a spatial discrimination. The behavioral paradigm used was an analogue of Leonard's 5-choice serial reaction time task for humans. The 6-OHDA lesion produced an 87% depletion of dopamine (DA) in the NAS, only a minor (25%) depletion of DA in the anterior caudate, and a 75% depletion of neocortical noradrenaline (NA). The lesion transiently attenuated both the speed and impulsivity of responding on the baseline schedule, but did not affect discriminative accuracy. In addition, the lesion attenuated the increase in premature responding caused by both systemic administration of D-amphetamine and bursts of loud white noise, presented just prior to the onset of the visual discriminanda. However, the lesion did not affect discriminative accuracy in these 2 conditions. The lesion also only had extremely minor effects on performance of this paradigm when the intertrial intervals were unpredictable. These results contrast with the previously reported pattern of behavioral effects resulting from forebrain NA depletion in the same behavioral paradigm. They therefore complete a double dissociation of eff...Continue Reading

References

Jun 1, 1976·Journal of Comparative and Physiological Psychology·J F MarshallE M Stricker
Mar 1, 1975·Psychological Review·K H Pribram, D McGuinness
Dec 16, 1977·Science·F A Gonzalez, L D Byrd

❮ Previous
Next ❯

Citations

Jul 1, 1995·Psychopharmacology·D N Jones, G A Higgins
Sep 1, 2004·Psychopharmacology·Mohammed Shoaib, Lisiane Bizarro
Sep 20, 2006·Psychopharmacology·Saleem M Nicola
Mar 6, 2009·Psychopharmacology·Yolanda Peña OliverDavid N Stephens
May 14, 2009·Psychopharmacology·Tommy PattijAnton N M Schoffelmeer
Oct 20, 2009·Psychopharmacology·Valerie VoonMark Hallett
Dec 3, 2011·Psychopharmacology·Petra J J Baarendse, Louk J M J Vanderschuren
Apr 6, 2013·Psychopharmacology·Alan C SwannF Gerard Moeller
Jul 19, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gail Tripp, Jeff Wickens
Jul 19, 1991·Brain Research·S Puglisi-AllegraS Cabib
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·P JäkäläP J Riekkinen
Jun 1, 1996·Brain Research. Cognitive Brain Research·J L Muir
Jun 1, 1996·Brain Research. Cognitive Brain Research·J C Bizot, M H Thiébot
Jun 1, 1996·Brain Research. Cognitive Brain Research·J S Andrews
Jun 11, 2005·Neurobiology of Learning and Memory·Maïté HotteThérèse M Jay
May 24, 2003·Neuropharmacology·Britta HahnIan P Stolerman
Jan 1, 1997·Pharmacology, Biochemistry, and Behavior·S RuotsalainenJ Sirviö
Apr 1, 1997·Pharmacology, Biochemistry, and Behavior·T PuumalaJ Sirviö
Apr 1, 1997·Pharmacology, Biochemistry, and Behavior·J L Muir
Aug 13, 1998·Pharmacology, Biochemistry, and Behavior·G CrescimannoG Amato
Apr 2, 2003·Brain Research. Brain Research Reviews·Eugen DavidsRoss J Baldessarini
Jan 1, 2003·Journal of Affective Disorders·Alan C SwannF Gerard Moeller
Dec 21, 2002·Behavioural Brain Research·Filippo PassettiTrevor W Robbins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.